Novartis AG (NYSE: NVS) wants to get larger in teh realm of vaccines. In China for that matter. The Swiss drug giant has announced plans to buy an 85% majority stake in a privately held Chinese vaccine maker called Zhejiang Tianyuan. The purchase price is roughly $125 million.
This is a [...]
